Congratulations to the 2021 Telly Award Winners!

The world of B2B has permanently shifted. Companies are creating holistic, owned media channels, powerful narratives and engaging, educational content – and the recently announced 2021 Telly Awards prove it!

 

Let’s take a look at the 2021 Telly Award-winning content produced by MarketScale and who helped bring it to life.

 

Silver Telly, Campaign-Series: Non-Scripted Documentary:
Down to Earth – The Ozarks, Presented by Microdrones

Down to Earth highlights the depth of what’s possible in the realm of original B2B content.

By engaging its audience with a reality series worthy of any major television network, Microdrones entertains its audience while educating them on how the organization’s solutions solve very real challenges for very real end users.

 

Silver Telly, General B2B Branded Content:
Being Brunel Museum, Presented by Electrosonic

In a year defined by challenges gathering in person, this content took viewers on a journey inside a unique and memorable museum experience – without them ever setting foot on the grounds.

Video is a powerful way to communicate with audiences and show them, not tell them, the things that set an organization apart.

 

Silver Telly, 3D Animation:
Clarus Flex Wall, Presented by Clarus

The impact of 3D is nearly immeasurable. It empowers potential customers to see how products and solutions fit into 3D spaces and interact with other elements of a space, giving them a special understanding of a product without ever seeing it in person.

Plus, it’s just flat-out cool.

In this video, audiences were shown exactly how the Clarus Flex Wall could benefit their evolving workspace, offering an opportunity to share and educate regardless of where the audience is located. That’s powerful stuff.

 

The future of B2B will be driven by content that builds audiences, engages, entertains and educates them, and positions organizations as true thought leaders.

And that future is just beginning. We can’t wait to see what we make next!

 

 

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More